Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

Author： Banna Giuseppe   Bettio Daniela   Scorsetti Marta   Navarria Pierina   Simonelli Matteo   Rodriguez Baena Riccardo   Aimar Enrico   Gaetani Paolo   Colombo PierGiuseppe   Rognone Felice   Santoro Armando  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.81, Iss.3, 2007-02, pp. : 323-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children

By Broniscer Alberto   Chintagumpala Murali   Fouladi Maryam   Krasin Matthew   Kocak Mehmet   Bowers Daniel   Iacono Lisa   Merchant Thomas   Stewart Clinton   Houghton Peter   Kun Larry   Ledet Davonna   Gajjar Amar  

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 313-319

Springer Publishing Company

Access to resources Recommend Favorite

Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas

By Brown Paul   Ballman Karla   Rummans Teresa   Maurer Matthew   Sloan Jeff   Boeve Bradley   Gupta Lalit   Tang-Wai David   Arusell Robert   Clark Matthew   Buckner Jan  

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 283-291

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Newly Diagnosed Glioblastoma with Concomitant and Adjuvant Temozolomide and Radiotherapy: UK Experience

By Beresford Mark J.   Power Danielle   Alexander Emma   Brock Cathryn   Thompson Julian   Roncaroli Federico   Waldman Adam D.   James van Dellen   Glaser Mark  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 427-432

Adis International

Access to resources Recommend Favorite

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

By Balaña Carmen   López-pousa Antonio   Berrocal Alfonso   Yaya-tur Ricardo   Herrero Ana   García Jose-luis   Martín-broto Javier   Benavides Manuel   Cerdá-nicolás Miguel   Ballester Rosa   Balart Josep   Capellades Jaume  

Journal of Neuro-Oncology, Vol. 70, Iss. 3, 2004-12 ,pp. : 359-370

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

By Peereboom David   Shepard Dale   Ahluwalia Manmeet   Brewer Cathy   Agarwal Neeraj   Stevens Glen   Suh John   Toms Steven   Vogelbaum Michael   Weil Robert   Elson Paul   Barnett Gene  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 93-99

Springer Publishing Company

Access to resources Recommend Favorite